Depreciation in USD of IGC Pharma, Inc. from 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
IGC Pharma, Inc. quarterly/annual Depreciation history and change rate from 2011 to Q3 2025.
  • IGC Pharma, Inc. Depreciation for the quarter ending 30 Sep 2025 was $105,000.000, a 27.6% decline year-over-year.
  • IGC Pharma, Inc. Depreciation for the twelve months ending 30 Sep 2025 was $512,000.000, a 10.6% decline year-over-year.
  • IGC Pharma, Inc. annual Depreciation for 2024 was $567,000.000, a 0.71% increase from 2023.
  • IGC Pharma, Inc. annual Depreciation for 2023 was $563,000.000, a 35% increase from 2022.
  • IGC Pharma, Inc. annual Depreciation for 2022 was $417,000.000, a 33.5% decline from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

IGC Pharma, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $512,000 $105,000 -$40,000 -27.6% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 $552,000 $127,000 -$15,000 -10.6% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $567,000 $136,000 -$10,000 -6.8% 01 Jan 2025 31 Mar 2025 10-K 27 Jun 2025
Q4 2024 $577,000 $144,000 +$4,000 +2.9% 01 Oct 2024 31 Dec 2024 10-Q 14 Feb 2025
Q3 2024 $573,000 $145,000 +$5,000 +3.6% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q2 2024 $568,000 $142,000 +$5,000 +3.6% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 $563,000 $146,000 +$195,000 01 Jan 2024 31 Mar 2024 10-K 27 Jun 2025
Q4 2023 $368,000 $140,000 -$18,000 -11.4% 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2025
Q3 2023 $386,000 $140,000 -$16,000 -10.3% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 $402,000 $137,000 -$15,000 -9.9% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024
Q1 2023 $417,000 -$49,000 -$250,000 -1.2% 01 Jan 2023 31 Mar 2023 10-K 24 Jun 2024
Q4 2022 $667,000 $158,000 +$41,000 +35% 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024
Q3 2022 $626,000 $156,000 -$1,000 -0.64% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $627,000 $152,000 $0 0% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 $627,000 $201,000 +$71,000 +54.6% 01 Jan 2022 31 Mar 2022 10-K 07 Jul 2023
Q4 2021 $556,000 $117,000 -$7,000 -5.6% 01 Oct 2021 31 Dec 2021 10-Q 14 Feb 2023
Q3 2021 $563,000 $157,000 +$53,000 +51% 01 Jul 2021 30 Sep 2021 10-Q 01 Nov 2022
Q2 2021 $510,000 $152,000 +$48,000 +46.2% 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2022
Q1 2021 $462,000 $130,000 +$59,000 +83.1% 01 Jan 2021 31 Mar 2021 10-K 23 Jun 2022
Q4 2020 $403,000 $124,000 +$102,000 +4.6% 01 Oct 2020 31 Dec 2020 10-Q 10 Feb 2022
Q3 2020 $301,000 $104,000 +$80,000 +3.3% 01 Jul 2020 30 Sep 2020 10-Q 20 Nov 2020
Q2 2020 $221,000 $104,000 +$87,000 +5.1% 01 Apr 2020 30 Jun 2020 10-Q 29 Oct 2021
Q1 2020 $134,000 $71,000 01 Jan 2020 31 Mar 2020 10-K 14 Jun 2021
Q4 2019 $22,000 +$7,000 +46.7% 01 Oct 2019 31 Dec 2019 10-Q 16 Feb 2021
Q3 2019 $24,000 01 Jul 2019 30 Sep 2019 10-Q 20 Nov 2020
Q2 2019 $17,000 01 Apr 2019 30 Jun 2019 10-Q 19 Aug 2020
Q4 2018 $15,000 01 Oct 2018 31 Dec 2018 10-Q 10 Feb 2020
Q2 2014 $148,889 -$405 -0.27% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2014
Q2 2013 $149,294 +$65,700 +78.6% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014
Q2 2012 $83,594 01 Apr 2012 30 Jun 2012 10-Q 16 Aug 2013

IGC Pharma, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $567,000 +$4,000 +0.71% 01 Apr 2024 31 Mar 2025 10-K 27 Jun 2025
2023 $563,000 +$146,000 +35% 01 Apr 2023 31 Mar 2024 10-K 27 Jun 2025
2022 $417,000 -$210,000 -33.5% 01 Apr 2022 31 Mar 2023 10-K 24 Jun 2024
2021 $627,000 +$165,000 +35.7% 01 Apr 2021 31 Mar 2022 10-K 07 Jul 2023
2020 $462,000 +$328,000 +2.4% 01 Apr 2020 31 Mar 2021 10-K 23 Jun 2022
2019 $134,000 +$75,000 +1.3% 01 Apr 2019 31 Mar 2020 10-K 14 Jun 2021
2018 $59,000 01 Apr 2018 31 Mar 2019 10-K 13 Jul 2020
2013 $712,314 +$38,398 +5.7% 01 Apr 2013 31 Mar 2014 10-K 15 Jul 2014
2012 $673,916 -$322,487 -32.4% 01 Apr 2012 31 Mar 2013 10-K 15 Jul 2014
2011 $996,403 01 Apr 2011 31 Mar 2012 10-K 15 Jul 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.